Author

R. F. Relich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Griffin· 1 shared A. Marzi· 1 shared B. Rostama· 1 shared J.-P. Lavik· 1 shared K. L. O'Donnell· 1 shared K. Shifflett· 1 shared M. K. Zimmerman· 1 shared M. May· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Griffin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern

A. Marzi, A. Griffin, K. L. O'Donnell, K. Shifflett, J.-P. Lavik, P. M. Russell, M. K. Zimmerman, R. F. Relich

The paper examines serum from early pandemic SARS-CoV-2 patients, finding limited cross-neutralization against variants of concern.

bioRxiv · Nov 10, 2021Microbiology

Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV

M. May, B. Rostama, R. F. Relich

The paper analyzes the evolutionary dynamics and selectomes of SARS-CoV-2, SARS-CoV, and MERS-CoV to identify sites under diversifying selection and evolvability for vaccine and diagnostic applications.

bioRxiv · May 5, 2020 · PreprintMicrobiology